相关实验视频
Updated: Jul 2, 2025

08:20
Genome Engineering of Primary Human B Cells Using CRISPR/Cas9
Published on: November 3, 2020
6.3K
为高效的CRISPR基因编辑疗法提供循环增强的多氨基向量
Xianqing Wang1, Yinghao Li1, Sigen A2
1Charles Institute of Dermatology, School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.
概括
新的循环多β-氨基 (CPAE) 显示了基因传递的增强. 宏循环CPAE可以改善DNA吸收和基因表达,显示出在衰退性缩性表皮溶解中基因编辑的潜力.
科学领域:
- 生物材料科学 生物材料科学
- 基因治疗 基因治疗
- 聚合物化学 聚合物化学
背景情况:
- 聚β氨基 (PAE) 是具有不断变化的结构的多功能非病毒基因传递载体.
- 高分支的PAE (HPAE) 已经证明了基因传递效率的提高.
- 需要新的PAE架构,具有改进的转染能力.
研究的目的:
- 引入和描述一种用于基因传递的新类周期性PAE (CPAE).
- 为了评估CPAE与HPAE相比,CPAE的基因转染性能.
- 评估优化CPAE在患者衍生细胞中的CRISPR-Cas9基因编辑方面的潜力.
主要方法:
- 使用A2 + B4 + C2循环化策略合成循环PAE (CPAE).
- 使用二维NMR和光发光的CPAE结构的表征.
- 在体外评估DNA输送,细胞内吸收,基因表达和生物相容性.
- 应用MCPAE来输送CRISPR-Cas9等离子体用于RDEB角质细胞中的基因编辑.
主要成果:
- 合成和确认了两组CPAE,它们具有不同的环尺寸和拓.
- 宏循环CPAE (MCPAE) 与HPAE相比,显著增强了DNA细胞内摄取和基因表达.
- MCPAE 显示出极好的生物相容性.
- MCPAEs成功地将CRISPR-Cas9等离子体输入RDEB患者衍生的角质细胞中,实现了针对性的基因编辑.
结论:
- 循环PAE,特别是MCPAE,代表了非病毒基因传递载体的有希望的进步.
- MCPAE提供优越的基因转染性能和生物相容性.
- 在治疗基因编辑应用中,MCPAE具有显著的潜力,包括在RDEB等遗传疾病中.
相关概念视频
CRISPR
51.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.0K
Homologous Recombination
50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K

